热门资讯> 正文
ReShape Lifesciences公开募股定价260万美元
2025-06-10 00:18
- ReShape Lifesciences (NASDAQ:RSLS) on Monday announced the pricing of its public offering of 1.05M shares of common stock at a public offering price of $2.50 per share for gross proceeds of about $2.6M.
- The offering is expected to close on or about June 9, 2025, subject to the satisfaction of customary closing conditions.
- RSLS is -38.27% to $2.58.
- Source: Press Release
More on ReShape Lifesciences
- Financial information for ReShape Lifesciences
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
